Metraipolis › archive › dc_b296405ebc57

BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic target — Europe PMC PMID:41053095

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41053095
DOI
10.1038/s41420-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-09T13:08:05.403Z
SHA-256 of the archived text
28515dc67f5451f2c02235dcea00466ea9eddc1a37014be41508213a71a217ca
Stable URL of this page
https://metraipolis.com/documento/dc_b296405ebc57

How to cite

BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic target — Europe PMC PMID:41053095 — Europe PMC (en), https://europepmc.org/article/MED/41053095 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b296405ebc57 (Metraipolis archive dc_b296405ebc57, sha256 28515dc67f5451f2c02235dcea00466ea9eddc1a37014be41508213a71a217ca)
BibTeX
@misc{dcb296405ebc57,
  title = {BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic target — Europe PMC PMID:41053095},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41053095},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b296405ebc57; sha256 28515dc67f5451f2c02235dcea00466ea9eddc1a37014be41508213a71a217ca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41053095. Agents can read the archived copy with the MCP tool read_document.